Applying AI-ECG Solutions to Expand Clinical Utility
MyoVista Insights cloud-native software works with 12-lead ECGs from major manufacturers including GE, Philips, Mortara, and Cardioline. Pair with our wavECG for optimized signal capture, or use your existing equipment.
MyoVista Insights
Advanced AI algorithms that analyze ECG signals to detect subtle patterns indicating cardiac dysfunction, often years before symptoms appear.
- FDA 510(k) cleared for clinical use
- Detection of 12+ cardiac conditions
- 87% sensitivity in clinical validation
- Results in under 60 seconds
- Seamless EHR integration
- Comprehensive clinical reporting
MyoVista® wavECG™ Device
Optional high-fidelity ECG acquisition optimized for AI analysis. Pair with MyoVista Insights for enhanced signal capture, or use your existing ECG equipment.
- Works with MyoVista Insights or standalone
- 12-lead ECG with enhanced signal fidelity
- Portable and battery-powered
- Wireless connectivity
- Compatible with existing workflows
- FDA cleared, CE marked
Cloud Platform
Enterprise-grade cloud infrastructure for secure, scalable deployment across your healthcare system.
- HIPAA compliant infrastructure
- Real-time processing at scale
- Multi-site deployment support
- Comprehensive audit logging
- API access for custom integrations
- Population health analytics
Ready to Improve Cardiac Detection?
See how 12 validated algorithms can help your clinicians detect cardiac dysfunction earlier. Schedule a 30-minute demo with our clinical team.